Last updated: 2026-09-07 21:22:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Alpha Teknova, Inc. (TKNO) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $6.92, with a market capitalisation of $371.52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.91 to $7.84. This page covers its latest market performance, valuation, price trends and company information.
$371.52M | |
$7.15 | |
$30.89 | |
$1.16 | |
$7.24 | |
122.99K | |
210.55K | |
-- | |
$7.84 | |
$1.91 | |
-- | |
-- |
Alpha Teknova, Inc. (TKNO) last closed at $7.24 as of 2026-09-04 23:57:00, unchanged from the previous close of $7.24.
During the latest regular trading session, TKNO traded between $1.16 and $30.89, with a volume of 122.99K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Alpha Teknova, Inc. (TKNO) moved from $7.31 to $6.92, representing a decline of 5.31% ($0.39).
The stock traded between $6.82 and $7.64 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 146.32 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 84.5%
TKNO is currently trading at $6.92, placing it 84.5% of the way from its 52-week low of $1.91 to its 52-week high of $7.84. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 158 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Alpha Teknova, Inc. (TKNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.